| Dr Frank C Caillet, MD | |
|
4650 Amb Caffery Pkwy, Ste 101, Lafayette, LA 70508-6926 | |
| (337) 981-3363 | |
| (337) 981-3364 |
| Full Name | Dr Frank C Caillet |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 4650 Amb Caffery Pkwy, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245238021 | NPI | - | NPPES |
| 1493945 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 023036 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital & Clinics | Lafayette, LA | Hospital |
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Hospital And Clinics, Inc. | 7113161977 | 70 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
| Entity Name | Frank Caillet, Md, A Professional Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407972946 PECOS PAC ID: 6406747021 Enrollment ID: O20040323001086 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
| Entity Name | Lsuhn Billing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992975775 PECOS PAC ID: 0446337802 Enrollment ID: O20080409000372 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
| Entity Name | University Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639518087 PECOS PAC ID: 7113161977 Enrollment ID: O20130917000335 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
| Entity Name | Obhg Louisiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639567316 PECOS PAC ID: 9234443250 Enrollment ID: O20150805006718 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
| Entity Name | Southern Obgyn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174015945 PECOS PAC ID: 0446503627 Enrollment ID: O20181106000949 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
| Entity Name | Stephen Padgett Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336767805 PECOS PAC ID: 8921419953 Enrollment ID: O20201124001458 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank C Caillet, MD 4650 Amb Caffery Pkwy, Ste 101, Lafayette, LA 70508-6926 Ph: (337) 981-3363 | Dr Frank C Caillet, MD 4650 Amb Caffery Pkwy, Ste 101, Lafayette, LA 70508-6926 Ph: (337) 981-3363 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
For over a century, we have known that high altitude reduces the amount of blood the heart pumps around the body with each beat.
"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.
› Verified 8 days ago
Monique Michelle Monteilh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4640 Ambassador Caffery Pkwy, Lafayette, LA 70508 Phone: 337-984-1050 Fax: 337-984-8776 | |
Mika Marlaine King, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4640 Ambassador Caffery Pkwy, Lafayette, LA 70508 Phone: 337-984-1050 Fax: 337-984-8776 | |
Bobby Gene Nevils, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Lsu Central Clinic, 2390 West Congress Street, Lafayette, LA 70506 Phone: 337-261-6580 | |
Francis J Cardinale, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4600 Ambassador Caffery Pkwy, Lafayette, LA 70508 Phone: 337-521-9100 Fax: 337-470-2019 | |
Dr. Virginia S Singleton-alfred, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4600 Ambassador Caffery Pkwy, Lafayette, LA 70508 Phone: 337-521-9100 Fax: 337-470-2019 | |
Mr. Charles E. Padgett, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1211 Coolidge Street, Suite 405, Lafayette, LA 70503 Phone: 337-233-7524 Fax: 337-233-7567 | |
Perry Scott Barrilleaux, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4630 Ambassador Caffery Pkwy, Suite 204, Lafayette, LA 70508 Phone: 337-989-9826 |